BioCryst Pharmaceuticals, Inc.

BMV:BCRX * Stock Report

Market Cap: Mex$31.8b

BioCryst Pharmaceuticals Future Growth

Future criteria checks 4/6

BioCryst Pharmaceuticals is forecast to grow earnings and revenue by 72.8% and 15.3% per annum respectively while EPS is expected to grow by 72.6% per annum.

Key information

72.8%

Earnings growth rate

72.6%

EPS growth rate

Biotechs earnings growth0%
Revenue growth rate15.3%
Future return on equityn/a
Analyst coverage

Good

Last updated19 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BMV:BCRX * - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202662574170N/A8
12/31/2025534-14934610
12/31/2024446-785-529
9/30/2024413-124-57-56N/A
6/30/2024382-146-86-84N/A
3/31/2024355-209-104-101N/A
12/31/2023331-227-97-95N/A
9/30/2023318-236-112-110N/A
6/30/2023307-243-124-123N/A
3/31/2023290-226-133-132N/A
12/31/2022271-247-163-162N/A
9/30/2022238-193-172-170N/A
6/30/2022204-210-163-161N/A
3/31/2022188-194-162-159N/A
12/31/2021157-184-145-142N/A
9/30/2021114-227-154-152N/A
6/30/202179-214-168-167N/A
3/31/202132-209-173-173N/A
12/31/202018-183-136-135N/A
9/30/202054-125-103-103N/A
6/30/202049-116-93-92N/A
3/31/202048-115-86-86N/A
12/31/201949-109-90-90N/A
9/30/201912-134-103-103N/A
6/30/201912-126-111-111N/A
3/31/201923-107-100-100N/A
12/31/201821-101-93-93N/A
9/30/201822-93-79-79N/A
6/30/201829-79N/A-56N/A
3/31/201820-77N/A-52N/A
12/31/201725-66N/A-41N/A
9/30/201730-51N/A-36N/A
6/30/201729-47N/A-42N/A
3/31/201731-47N/A-43N/A
12/31/201626-55N/A-53N/A
9/30/201622-69N/A-62N/A
6/30/201625-72N/A-58N/A
3/31/201646-51N/A-28N/A
12/31/201548-43N/A-13N/A
9/30/201549-37N/A-12N/A
6/30/201541-31N/A-8N/A
3/31/201517-50N/A-33N/A
12/31/201414-45N/A-39N/A
9/30/201419-39N/A-29N/A
6/30/201418-38N/A-28N/A
3/31/201417-36N/A-24N/A
12/31/201317-30N/A-27N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BCRX * is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (8.1%).

Earnings vs Market: BCRX * is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BCRX * is expected to become profitable in the next 3 years.

Revenue vs Market: BCRX *'s revenue (15.3% per year) is forecast to grow faster than the MX market (7.3% per year).

High Growth Revenue: BCRX *'s revenue (15.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BCRX *'s Return on Equity is forecast to be high in 3 years time


Discover growth companies